お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、安定同位体標識化合物の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に安定同位体標識化合物市場を分類しています。
本レポートでは世界の安定同位体標識化合物市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Rotem Industries Israel、Huayi Isotopes、ABX、CIL、Wosotop、Tayio Nippon Sanso、CMR、Cambridge Isotope Laboratories、Merck KGaA、Urenco Limited、Isosciences、Medical Isotopes、Omicron Biochemicals、BWX Technologies、Trace Sciences International、Alsachim、Perkinelmer

レポートは安定同位体標識化合物の主要生産者を調査し、主要地域や国の消費状況も提供します。安定同位体標識化合物の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Water-18O
    Oxygen-18O
    13C Labelled Compounds
    18F Labelled Compounds
    11C Labelled Compounds
    D Labelled Compounds
    2H Labelled Compounds
    15N Labelled Compounds
    Others

用途別の市場セグメント：
    Scientific Research
    Clinical Diagnostics
    Industrial
    Others

本レポートの詳細内容
本レポートは、世界の安定同位体標識化合物市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて安定同位体標識化合物市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の安定同位体標識化合物生産量、成長率、市場シェアを調査している。

二. 消費面では、安定同位体標識化合物の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの安定同位体標識化合物売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の安定同位体標識化合物市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本安定同位体標識化合物のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：安定同位体標識化合物のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 安定同位体標識化合物の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける安定同位体標識化合物の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章安定同位体標識化合物メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：安定同位体標識化合物の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：安定同位体標識化合物の主要メーカーの概要を提供し、製品の説明と仕様、安定同位体標識化合物の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：安定同位体標識化合物の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Stable Isotopically Labeled Compounds market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Stable Isotopically Labeled Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Stable Isotopically Labeled Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Stable Isotopically Labeled Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Stable Isotopically Labeled Compounds include Rotem Industries Israel, Huayi Isotopes, ABX, CIL, Wosotop, Tayio Nippon Sanso, CMR, Cambridge Isotope Laboratories and Merck KGaA, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Stable Isotopically Labeled Compounds production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Stable Isotopically Labeled Compounds by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Stable Isotopically Labeled Compounds, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Stable Isotopically Labeled Compounds, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Stable Isotopically Labeled Compounds, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Stable Isotopically Labeled Compounds sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Stable Isotopically Labeled Compounds market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Stable Isotopically Labeled Compounds sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Rotem Industries Israel
    Huayi Isotopes
    ABX
    CIL
    Wosotop
    Tayio Nippon Sanso
    CMR
    Cambridge Isotope Laboratories
    Merck KGaA
    Urenco Limited
    Isosciences
    Medical Isotopes
    Omicron Biochemicals
    BWX Technologies
    Trace Sciences International
    Alsachim
    Perkinelmer

Segment by Type
    Water-18O
    Oxygen-18O
    13C Labelled Compounds
    18F Labelled Compounds
    11C Labelled Compounds
    D Labelled Compounds
    2H Labelled Compounds
    15N Labelled Compounds
    Others

Segment by Application
    Scientific Research
    Clinical Diagnostics
    Industrial
    Others

Production by Region
    North America
    Europe
    China
    Japan

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Stable Isotopically Labeled Compounds production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Stable Isotopically Labeled Compounds in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Stable Isotopically Labeled Compounds manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stable Isotopically Labeled Compounds sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

List of Tables
    Table 1. Global Stable Isotopically Labeled Compounds Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Water-18O
    Table 3. Major Manufacturers of Oxygen-18O
    Table 4. Major Manufacturers of 13C Labelled Compounds
    Table 5. Major Manufacturers of 18F Labelled Compounds
    Table 6. Major Manufacturers of 11C Labelled Compounds
    Table 7. Major Manufacturers of D Labelled Compounds
    Table 8. Major Manufacturers of 2H Labelled Compounds
    Table 9. Major Manufacturers of 15N Labelled Compounds
    Table 10. Major Manufacturers of Others
    Table 11. Global Stable Isotopically Labeled Compounds Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Stable Isotopically Labeled Compounds Production by Region: 2019 VS 2023 VS 2030 (Tons)
    Table 13. Global Stable Isotopically Labeled Compounds Production by Region (2019-2024) & (Tons)
    Table 14. Global Stable Isotopically Labeled Compounds Production by Region (2025-2030) & (Tons)
    Table 15. Global Stable Isotopically Labeled Compounds Production Market Share by Region (2019-2024)
    Table 16. Global Stable Isotopically Labeled Compounds Production Market Share by Region (2025-2030)
    Table 17. Global Stable Isotopically Labeled Compounds Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 18. Global Stable Isotopically Labeled Compounds Revenue by Region (2019-2024) & (US$ Million)
    Table 19. Global Stable Isotopically Labeled Compounds Revenue by Region (2025-2030) & (US$ Million)
    Table 20. Global Stable Isotopically Labeled Compounds Revenue Market Share by Region (2019-2024)
    Table 21. Global Stable Isotopically Labeled Compounds Revenue Market Share by Region (2025-2030)
    Table 22. Global Stable Isotopically Labeled Compounds Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 23. Global Stable Isotopically Labeled Compounds Sales by Region (2019-2024) & (Tons)
    Table 24. Global Stable Isotopically Labeled Compounds Sales by Region (2025-2030) & (Tons)
    Table 25. Global Stable Isotopically Labeled Compounds Sales Market Share by Region (2019-2024)
    Table 26. Global Stable Isotopically Labeled Compounds Sales Market Share by Region (2025-2030)
    Table 27. Global Stable Isotopically Labeled Compounds Sales by Manufacturers (2019-2024) & (Tons)
    Table 28. Global Stable Isotopically Labeled Compounds Sales Share by Manufacturers (2019-2024)
    Table 29. Global Stable Isotopically Labeled Compounds Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 30. Global Stable Isotopically Labeled Compounds Revenue Share by Manufacturers (2019-2024)
    Table 31. Stable Isotopically Labeled Compounds Price by Manufacturers 2019-2024 (US$/Ton)
    Table 32. Global Key Players of Stable Isotopically Labeled Compounds, Industry Ranking, 2022 VS 2023 VS 2024
    Table 33. Global Stable Isotopically Labeled Compounds Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 34. Global Stable Isotopically Labeled Compounds by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stable Isotopically Labeled Compounds as of 2023)
    Table 35. Global Key Manufacturers of Stable Isotopically Labeled Compounds, Manufacturing Base Distribution and Headquarters
    Table 36. Global Key Manufacturers of Stable Isotopically Labeled Compounds, Product Offered and Application
    Table 37. Global Key Manufacturers of Stable Isotopically Labeled Compounds, Date of Enter into This Industry
    Table 38. Mergers & Acquisitions, Expansion Plans
    Table 39. Global Stable Isotopically Labeled Compounds Sales by Type (2019-2024) & (Tons)
    Table 40. Global Stable Isotopically Labeled Compounds Sales by Type (2025-2030) & (Tons)
    Table 41. Global Stable Isotopically Labeled Compounds Sales Share by Type (2019-2024)
    Table 42. Global Stable Isotopically Labeled Compounds Sales Share by Type (2025-2030)
    Table 43. Global Stable Isotopically Labeled Compounds Revenue by Type (2019-2024) & (US$ Million)
    Table 44. Global Stable Isotopically Labeled Compounds Revenue by Type (2025-2030) & (US$ Million)
    Table 45. Global Stable Isotopically Labeled Compounds Revenue Share by Type (2019-2024)
    Table 46. Global Stable Isotopically Labeled Compounds Revenue Share by Type (2025-2030)
    Table 47. Stable Isotopically Labeled Compounds Price by Type (2019-2024) & (US$/Ton)
    Table 48. Global Stable Isotopically Labeled Compounds Price Forecast by Type (2025-2030) & (US$/Ton)
    Table 49. Global Stable Isotopically Labeled Compounds Sales by Application (2019-2024) & (Tons)
    Table 50. Global Stable Isotopically Labeled Compounds Sales by Application (2025-2030) & (Tons)
    Table 51. Global Stable Isotopically Labeled Compounds Sales Share by Application (2019-2024)
    Table 52. Global Stable Isotopically Labeled Compounds Sales Share by Application (2025-2030)
    Table 53. Global Stable Isotopically Labeled Compounds Revenue by Application (2019-2024) & (US$ Million)
    Table 54. Global Stable Isotopically Labeled Compounds Revenue by Application (2025-2030) & (US$ Million)
    Table 55. Global Stable Isotopically Labeled Compounds Revenue Share by Application (2019-2024)
    Table 56. Global Stable Isotopically Labeled Compounds Revenue Share by Application (2025-2030)
    Table 57. Stable Isotopically Labeled Compounds Price by Application (2019-2024) & (US$/Ton)
    Table 58. Global Stable Isotopically Labeled Compounds Price Forecast by Application (2025-2030) & (US$/Ton)
    Table 59. US & Canada Stable Isotopically Labeled Compounds Sales by Type (2019-2024) & (Tons)
    Table 60. US & Canada Stable Isotopically Labeled Compounds Sales by Type (2025-2030) & (Tons)
    Table 61. US & Canada Stable Isotopically Labeled Compounds Revenue by Type (2019-2024) & (US$ Million)
    Table 62. US & Canada Stable Isotopically Labeled Compounds Revenue by Type (2025-2030) & (US$ Million)
    Table 63. US & Canada Stable Isotopically Labeled Compounds Sales by Application (2019-2024) & (Tons)
    Table 64. US & Canada Stable Isotopically Labeled Compounds Sales by Application (2025-2030) & (Tons)
    Table 65. US & Canada Stable Isotopically Labeled Compounds Revenue by Application (2019-2024) & (US$ Million)
    Table 66. US & Canada Stable Isotopically Labeled Compounds Revenue by Application (2025-2030) & (US$ Million)
    Table 67. US & Canada Stable Isotopically Labeled Compounds Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 68. US & Canada Stable Isotopically Labeled Compounds Revenue by Country (2019-2024) & (US$ Million)
    Table 69. US & Canada Stable Isotopically Labeled Compounds Revenue by Country (2025-2030) & (US$ Million)
    Table 70. US & Canada Stable Isotopically Labeled Compounds Sales by Country (2019-2024) & (Tons)
    Table 71. US & Canada Stable Isotopically Labeled Compounds Sales by Country (2025-2030) & (Tons)
    Table 72. Europe Stable Isotopically Labeled Compounds Sales by Type (2019-2024) & (Tons)
    Table 73. Europe Stable Isotopically Labeled Compounds Sales by Type (2025-2030) & (Tons)
    Table 74. Europe Stable Isotopically Labeled Compounds Revenue by Type (2019-2024) & (US$ Million)
    Table 75. Europe Stable Isotopically Labeled Compounds Revenue by Type (2025-2030) & (US$ Million)
    Table 76. Europe Stable Isotopically Labeled Compounds Sales by Application (2019-2024) & (Tons)
    Table 77. Europe Stable Isotopically Labeled Compounds Sales by Application (2025-2030) & (Tons)
    Table 78. Europe Stable Isotopically Labeled Compounds Revenue by Application (2019-2024) & (US$ Million)
    Table 79. Europe Stable Isotopically Labeled Compounds Revenue by Application (2025-2030) & (US$ Million)
    Table 80. Europe Stable Isotopically Labeled Compounds Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 81. Europe Stable Isotopically Labeled Compounds Revenue by Country (2019-2024) & (US$ Million)
    Table 82. Europe Stable Isotopically Labeled Compounds Revenue by Country (2025-2030) & (US$ Million)
    Table 83. Europe Stable Isotopically Labeled Compounds Sales by Country (2019-2024) & (Tons)
    Table 84. Europe Stable Isotopically Labeled Compounds Sales by Country (2025-2030) & (Tons)
    Table 85. China Stable Isotopically Labeled Compounds Sales by Type (2019-2024) & (Tons)
    Table 86. China Stable Isotopically Labeled Compounds Sales by Type (2025-2030) & (Tons)
    Table 87. China Stable Isotopically Labeled Compounds Revenue by Type (2019-2024) & (US$ Million)
    Table 88. China Stable Isotopically Labeled Compounds Revenue by Type (2025-2030) & (US$ Million)
    Table 89. China Stable Isotopically Labeled Compounds Sales by Application (2019-2024) & (Tons)
    Table 90. China Stable Isotopically Labeled Compounds Sales by Application (2025-2030) & (Tons)
    Table 91. China Stable Isotopically Labeled Compounds Revenue by Application (2019-2024) & (US$ Million)
    Table 92. China Stable Isotopically Labeled Compounds Revenue by Application (2025-2030) & (US$ Million)
    Table 93. Asia Stable Isotopically Labeled Compounds Sales by Type (2019-2024) & (Tons)
    Table 94. Asia Stable Isotopically Labeled Compounds Sales by Type (2025-2030) & (Tons)
    Table 95. Asia Stable Isotopically Labeled Compounds Revenue by Type (2019-2024) & (US$ Million)
    Table 96. Asia Stable Isotopically Labeled Compounds Revenue by Type (2025-2030) & (US$ Million)
    Table 97. Asia Stable Isotopically Labeled Compounds Sales by Application (2019-2024) & (Tons)
    Table 98. Asia Stable Isotopically Labeled Compounds Sales by Application (2025-2030) & (Tons)
    Table 99. Asia Stable Isotopically Labeled Compounds Revenue by Application (2019-2024) & (US$ Million)
    Table 100. Asia Stable Isotopically Labeled Compounds Revenue by Application (2025-2030) & (US$ Million)
    Table 101. Asia Stable Isotopically Labeled Compounds Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 102. Asia Stable Isotopically Labeled Compounds Revenue by Region (2019-2024) & (US$ Million)
    Table 103. Asia Stable Isotopically Labeled Compounds Revenue by Region (2025-2030) & (US$ Million)
    Table 104. Asia Stable Isotopically Labeled Compounds Sales by Region (2019-2024) & (Tons)
    Table 105. Asia Stable Isotopically Labeled Compounds Sales by Region (2025-2030) & (Tons)
    Table 106. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales by Type (2019-2024) & (Tons)
    Table 107. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales by Type (2025-2030) & (Tons)
    Table 108. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue by Type (2019-2024) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue by Type (2025-2030) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales by Application (2019-2024) & (Tons)
    Table 111. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales by Application (2025-2030) & (Tons)
    Table 112. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue by Application (2019-2024) & (US$ Million)
    Table 113. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue by Application (2025-2030) & (US$ Million)
    Table 114. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 115. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue by Country (2019-2024) & (US$ Million)
    Table 116. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue by Country (2025-2030) & (US$ Million)
    Table 117. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales by Country (2019-2024) & (Tons)
    Table 118. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales by Country (2025-2030) & (Tons)
    Table 119. Rotem Industries Israel Company Information
    Table 120. Rotem Industries Israel Description and Major Businesses
    Table 121. Rotem Industries Israel Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 122. Rotem Industries Israel Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Rotem Industries Israel Recent Development
    Table 124. Huayi Isotopes Company Information
    Table 125. Huayi Isotopes Description and Major Businesses
    Table 126. Huayi Isotopes Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 127. Huayi Isotopes Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Huayi Isotopes Recent Development
    Table 129. ABX Company Information
    Table 130. ABX Description and Major Businesses
    Table 131. ABX Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 132. ABX Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. ABX Recent Development
    Table 134. CIL Company Information
    Table 135. CIL Description and Major Businesses
    Table 136. CIL Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 137. CIL Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. CIL Recent Development
    Table 139. Wosotop Company Information
    Table 140. Wosotop Description and Major Businesses
    Table 141. Wosotop Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 142. Wosotop Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Wosotop Recent Development
    Table 144. Tayio Nippon Sanso Company Information
    Table 145. Tayio Nippon Sanso Description and Major Businesses
    Table 146. Tayio Nippon Sanso Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 147. Tayio Nippon Sanso Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Tayio Nippon Sanso Recent Development
    Table 149. CMR Company Information
    Table 150. CMR Description and Major Businesses
    Table 151. CMR Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 152. CMR Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. CMR Recent Development
    Table 154. Cambridge Isotope Laboratories Company Information
    Table 155. Cambridge Isotope Laboratories Description and Major Businesses
    Table 156. Cambridge Isotope Laboratories Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 157. Cambridge Isotope Laboratories Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Cambridge Isotope Laboratories Recent Development
    Table 159. Merck KGaA Company Information
    Table 160. Merck KGaA Description and Major Businesses
    Table 161. Merck KGaA Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 162. Merck KGaA Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. Merck KGaA Recent Development
    Table 164. Urenco Limited Company Information
    Table 165. Urenco Limited Description and Major Businesses
    Table 166. Urenco Limited Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 167. Urenco Limited Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 168. Urenco Limited Recent Development
    Table 169. Isosciences Company Information
    Table 170. Isosciences Description and Major Businesses
    Table 171. Isosciences Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 172. Isosciences Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 173. Isosciences Recent Development
    Table 174. Medical Isotopes Company Information
    Table 175. Medical Isotopes Description and Major Businesses
    Table 176. Medical Isotopes Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 177. Medical Isotopes Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 178. Medical Isotopes Recent Development
    Table 179. Omicron Biochemicals Company Information
    Table 180. Omicron Biochemicals Description and Major Businesses
    Table 181. Omicron Biochemicals Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 182. Omicron Biochemicals Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 183. Omicron Biochemicals Recent Development
    Table 184. BWX Technologies Company Information
    Table 185. BWX Technologies Description and Major Businesses
    Table 186. BWX Technologies Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 187. BWX Technologies Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 188. BWX Technologies Recent Development
    Table 189. Trace Sciences International Company Information
    Table 190. Trace Sciences International Description and Major Businesses
    Table 191. Trace Sciences International Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 192. Trace Sciences International Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 193. Trace Sciences International Recent Development
    Table 194. Alsachim Company Information
    Table 195. Alsachim Description and Major Businesses
    Table 196. Alsachim Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 197. Alsachim Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 198. Alsachim Recent Development
    Table 199. Perkinelmer Company Information
    Table 200. Perkinelmer Description and Major Businesses
    Table 201. Perkinelmer Stable Isotopically Labeled Compounds Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 202. Perkinelmer Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
    Table 203. Perkinelmer Recent Development
    Table 204. Key Raw Materials Lists
    Table 205. Raw Materials Key Suppliers Lists
    Table 206. Stable Isotopically Labeled Compounds Distributors List
    Table 207. Stable Isotopically Labeled Compounds Customers List
    Table 208. Stable Isotopically Labeled Compounds Market Trends
    Table 209. Stable Isotopically Labeled Compounds Market Drivers
    Table 210. Stable Isotopically Labeled Compounds Market Challenges
    Table 211. Stable Isotopically Labeled Compounds Market Restraints
    Table 212. Research Programs/Design for This Report
    Table 213. Key Data Information from Secondary Sources
    Table 214. Key Data Information from Primary Sources
List of Figures
    Figure 1. Stable Isotopically Labeled Compounds Product Picture
    Figure 2. Global Stable Isotopically Labeled Compounds Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Stable Isotopically Labeled Compounds Market Share by Type in 2023 & 2030
    Figure 4. Water-18O Product Picture
    Figure 5. Oxygen-18O Product Picture
    Figure 6. 13C Labelled Compounds Product Picture
    Figure 7. 18F Labelled Compounds Product Picture
    Figure 8. 11C Labelled Compounds Product Picture
    Figure 9. D Labelled Compounds Product Picture
    Figure 10. 2H Labelled Compounds Product Picture
    Figure 11. 15N Labelled Compounds Product Picture
    Figure 12. Others Product Picture
    Figure 13. Global Stable Isotopically Labeled Compounds Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 14. Global Stable Isotopically Labeled Compounds Market Share by Application in 2023 & 2030
    Figure 15. Scientific Research
    Figure 16. Clinical Diagnostics
    Figure 17. Industrial
    Figure 18. Others
    Figure 19. Stable Isotopically Labeled Compounds Report Years Considered
    Figure 20. Global Stable Isotopically Labeled Compounds Capacity, Production and Utilization (2019-2030) & (Tons)
    Figure 21. Global Stable Isotopically Labeled Compounds Production Market Share by Region in Percentage: 2023 Versus 2030
    Figure 22. Global Stable Isotopically Labeled Compounds Production Market Share by Region (2019-2030)
    Figure 23. Stable Isotopically Labeled Compounds Production Growth Rate in North America (2019-2030) & (Tons)
    Figure 24. Stable Isotopically Labeled Compounds Production Growth Rate in Europe (2019-2030) & (Tons)
    Figure 25. Stable Isotopically Labeled Compounds Production Growth Rate in China (2019-2030) & (Tons)
    Figure 26. Stable Isotopically Labeled Compounds Production Growth Rate in Japan (2019-2030) & (Tons)
    Figure 27. Global Stable Isotopically Labeled Compounds Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 28. Global Stable Isotopically Labeled Compounds Revenue 2019-2030 (US$ Million)
    Figure 29. Global Stable Isotopically Labeled Compounds Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Figure 30. Global Stable Isotopically Labeled Compounds Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 31. Global Stable Isotopically Labeled Compounds Revenue Market Share by Region (2019-2030)
    Figure 32. Global Stable Isotopically Labeled Compounds Sales 2019-2030 ((Tons)
    Figure 33. Global Stable Isotopically Labeled Compounds Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
    Figure 34. Global Stable Isotopically Labeled Compounds Sales Market Share by Region (2019-2030)
    Figure 35. US & Canada Stable Isotopically Labeled Compounds Sales YoY (2019-2030) & (Tons)
    Figure 36. US & Canada Stable Isotopically Labeled Compounds Revenue YoY (2019-2030) & (US$ Million)
    Figure 37. Europe Stable Isotopically Labeled Compounds Sales YoY (2019-2030) & (Tons)
    Figure 38. Europe Stable Isotopically Labeled Compounds Revenue YoY (2019-2030) & (US$ Million)
    Figure 39. China Stable Isotopically Labeled Compounds Sales YoY (2019-2030) & (Tons)
    Figure 40. China Stable Isotopically Labeled Compounds Revenue YoY (2019-2030) & (US$ Million)
    Figure 41. Asia (excluding China) Stable Isotopically Labeled Compounds Sales YoY (2019-2030) & (Tons)
    Figure 42. Asia (excluding China) Stable Isotopically Labeled Compounds Revenue YoY (2019-2030) & (US$ Million)
    Figure 43. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales YoY (2019-2030) & (Tons)
    Figure 44. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue YoY (2019-2030) & (US$ Million)
    Figure 45. The Stable Isotopically Labeled Compounds Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 46. The Top 5 and 10 Largest Manufacturers of Stable Isotopically Labeled Compounds in the World: Market Share by Stable Isotopically Labeled Compounds Revenue in 2023
    Figure 47. Global Stable Isotopically Labeled Compounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 48. Global Stable Isotopically Labeled Compounds Sales Market Share by Type (2019-2030)
    Figure 49. Global Stable Isotopically Labeled Compounds Revenue Market Share by Type (2019-2030)
    Figure 50. Global Stable Isotopically Labeled Compounds Sales Market Share by Application (2019-2030)
    Figure 51. Global Stable Isotopically Labeled Compounds Revenue Market Share by Application (2019-2030)
    Figure 52. US & Canada Stable Isotopically Labeled Compounds Sales Market Share by Type (2019-2030)
    Figure 53. US & Canada Stable Isotopically Labeled Compounds Revenue Market Share by Type (2019-2030)
    Figure 54. US & Canada Stable Isotopically Labeled Compounds Sales Market Share by Application (2019-2030)
    Figure 55. US & Canada Stable Isotopically Labeled Compounds Revenue Market Share by Application (2019-2030)
    Figure 56. US & Canada Stable Isotopically Labeled Compounds Revenue Share by Country (2019-2030)
    Figure 57. US & Canada Stable Isotopically Labeled Compounds Sales Share by Country (2019-2030)
    Figure 58. U.S. Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 59. Canada Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 60. Europe Stable Isotopically Labeled Compounds Sales Market Share by Type (2019-2030)
    Figure 61. Europe Stable Isotopically Labeled Compounds Revenue Market Share by Type (2019-2030)
    Figure 62. Europe Stable Isotopically Labeled Compounds Sales Market Share by Application (2019-2030)
    Figure 63. Europe Stable Isotopically Labeled Compounds Revenue Market Share by Application (2019-2030)
    Figure 64. Europe Stable Isotopically Labeled Compounds Revenue Share by Country (2019-2030)
    Figure 65. Europe Stable Isotopically Labeled Compounds Sales Share by Country (2019-2030)
    Figure 66. Germany Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 67. France Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 68. U.K. Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 69. Italy Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 70. Russia Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 71. China Stable Isotopically Labeled Compounds Sales Market Share by Type (2019-2030)
    Figure 72. China Stable Isotopically Labeled Compounds Revenue Market Share by Type (2019-2030)
    Figure 73. China Stable Isotopically Labeled Compounds Sales Market Share by Application (2019-2030)
    Figure 74. China Stable Isotopically Labeled Compounds Revenue Market Share by Application (2019-2030)
    Figure 75. Asia Stable Isotopically Labeled Compounds Sales Market Share by Type (2019-2030)
    Figure 76. Asia Stable Isotopically Labeled Compounds Revenue Market Share by Type (2019-2030)
    Figure 77. Asia Stable Isotopically Labeled Compounds Sales Market Share by Application (2019-2030)
    Figure 78. Asia Stable Isotopically Labeled Compounds Revenue Market Share by Application (2019-2030)
    Figure 79. Asia Stable Isotopically Labeled Compounds Revenue Share by Region (2019-2030)
    Figure 80. Asia Stable Isotopically Labeled Compounds Sales Share by Region (2019-2030)
    Figure 81. Japan Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 82. South Korea Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 83. China Taiwan Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 84. Southeast Asia Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 85. India Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 86. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales Market Share by Type (2019-2030)
    Figure 87. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue Market Share by Type (2019-2030)
    Figure 88. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales Market Share by Application (2019-2030)
    Figure 89. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue Market Share by Application (2019-2030)
    Figure 90. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Revenue Share by Country (2019-2030)
    Figure 91. Middle East, Africa and Latin America Stable Isotopically Labeled Compounds Sales Share by Country (2019-2030)
    Figure 92. Brazil Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 93. Mexico Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 94. Turkey Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 95. Israel Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 96. GCC Countries Stable Isotopically Labeled Compounds Revenue (2019-2030) & (US$ Million)
    Figure 97. Stable Isotopically Labeled Compounds Value Chain
    Figure 98. Stable Isotopically Labeled Compounds Production Process
    Figure 99. Channels of Distribution
    Figure 100. Distributors Profiles
    Figure 101. Bottom-up and Top-down Approaches for This Report
    Figure 102. Data Triangulation
    Figure 103. Key Executives Interviewed